Episode 1 led the pre-seed round for the software discovery platform alongside Dreamcraft and Portfolio Ventures.
"We’ve spent our careers building startups, and we learned firsthand that a company’s success is tied to the technology it chooses. These decisions can make or break products, and often shape the long-term fate of an entire business. As seasoned engineering and data leaders, we’ve built tech infrastructure from the ground up, making tough, high-stakes calls along the way. We didn’t always get things right. Tech moves quickly, but there’s a lack of reliable, up-to-date guidance to make these critical decisions. That gap revealed a huge opportunity for us to help organisations unlock their true potential and embrace modern tools with confidence in the age of AI. We’re building Dragonfly to be the technology companion we always wished we had – one that empowers every company to make faster, better choices about the software they use to build and scale."
The grant from the US Advanced Research Projects Agency for Health will support the POSEIDON programme for early oncology intervention.
"The field of cancer screening needs a revolution, and POSEIDON stands ready to deliver. The program allows for a better future by creating broadly accessible, at-home tests that will accurately detect 30+ cancers as early as Stage I, when tumours are still small and the chances of survival are high,"
AlbionVC led the investment round alongside Portage Ventures and MS&AD to support team expansion.
"Growing institutional participation is transforming crypto markets and creating a greater need for credible, independent risk intelligence. Agio Ratings provides a clear, data-driven view of the probability of default for exchanges and other institutions, and their alerts deliver a valuable independent signal alongside our own monitoring by flagging anomalous transaction patterns."
The seed round was led by Nexus Venture Partners with participation from athlete investment collective 4CAST.
"The medical tourism market holds immense untapped value, and The Medical Travel Company’s full-stack model is the key to unlocking it. Having founded one of India’s most successful consumer-tech stories, Sahil, Ankit and their team are uniquely positioned to build trust and capture this opportunity. India has long been a leading medical frontier, with world-class practitioners and cutting-edge technology; it’s about time this excellence is made globally accessible"
Connect Ventures led the pre-seed round as the company emerged from stealth.
"While the TMS is the system of record for our customers, many of the conversations, decisions and data that drive freight never make it inside. That missing information is where revenue is lost and service breaks down. Bridging that gap is the only way to unlock real automation and enable the revenue growth and operational resilience forwarders need in today's market. Rates and contracts underpin freight forwarding, and are especially pertinent in the current environment. Starting here enables the biggest commercial impact for our customers while building the core grounding for future automation for our customers."